By mimicking the GLP-1 hormone, it helps control blood sugar levels, reduces appetite, and slows down the emptying of the stomach
Semaglutide Regulatory Status in Canada Health Canada Approval Status (Ozempic, Wegovy, Rybelsus, Generic) Semaglutide is the active ingredient in three Novo Nordisk products authorized for sale in Canada: Ozempic (authorized 2018 for type 2 diabetes, with an expanded indication in 2024 to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes), Rybelsus (oral semaglutide tablets authorized for type 2 diabetes), and Wegovy (authorized 2021 for chronic weight management, with an expanded indication in 2024 to reduce the risk of non-fatal myocardial infarction, and a Notice of Compliance with Conditions issued in December 2025 for non-cirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis)
With over two decades of expertise and an impressive track record of 80,000+ procedures, we have refined our approach to deliver personalized, high-quality treatments
For women who havent responded well to metformin alone, adding a GLP-1 receptor agonist can be a game-changer
Klinic handles the paperwork, follows up with your insurer, and assists with appeals if needed
SUGESTO DE USO: Sugere-se a ingesto de 4 cpsulas ao dia
